UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Book Chapter (1329) 1329
Journal Article (596) 596
Patent (182) 182
Conference Proceeding (6) 6
Publication (6) 6
Reference (2) 2
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (301) 301
science & technology (288) 288
life sciences & biomedicine (272) 272
peptides (176) 176
chemistry (173) 173
metallurgy (173) 173
organic chemistry (172) 172
male (163) 163
female (161) 161
middle aged (159) 159
microbiology (158) 158
biochemistry (157) 157
beer (156) 156
enzymology (156) 156
mutation or genetic engineering (156) 156
spirits (156) 156
vinegar (156) 156
wine (156) 156
oncology (146) 146
compositions thereof (139) 139
culture media (139) 139
microorganisms or enzymes (139) 139
propagating, preserving or maintaining microorganisms (139) 139
human necessities (129) 129
hygiene (129) 129
medical or veterinary science (129) 129
adult (127) 127
aged (126) 126
preparations for medical, dental, or toilet purposes (124) 124
physics (122) 122
investigating or analysing materials by determining theirchemical or physical properties (119) 119
measuring (119) 119
testing (119) 119
compositions or test papers therefor (115) 115
condition-responsive control in microbiological orenzymological processes (115) 115
measuring or testing processes involving enzymes, nucleicacids or microorganisms (115) 115
processes of preparing such compositions (115) 115
hematology (103) 103
fermentation or enzyme-using processes to synthesise a desiredchemical compound or composition or to separate optical isomersfrom a racemic mixture (70) 70
treatment outcome (68) 68
adolescent (66) 66
antineoplastic combined chemotherapy protocols - therapeutic use (59) 59
abridged index medicus (57) 57
prognosis (51) 51
rituximab (49) 49
specific therapeutic activity of chemical compounds ormedicinal preparations (49) 49
aged, 80 and over (45) 45
lymphomas (44) 44
young adult (44) 44
antigens, neoplasm - immunology (42) 42
cyclophosphamide - administration & dosage (42) 42
doxorubicin - administration & dosage (41) 41
immunology (41) 41
nucleic acids (41) 41
sugars (41) 41
derivatives thereof (40) 40
nucleosides (40) 40
nucleotides (40) 40
vincristine - administration & dosage (39) 39
antineoplastic combined chemotherapy protocols - administration & dosage (38) 38
cancer (38) 38
disease-free survival (36) 36
prednisone - administration & dosage (35) 35
animals (33) 33
lymphoma, large b-cell, diffuse - drug therapy (33) 33
risk factors (33) 33
chemotherapy (32) 32
survival analysis (28) 28
analysis (27) 27
lymphoma (26) 26
antibodies, monoclonal - therapeutic use (24) 24
antigens, neoplasm - genetics (24) 24
immunotherapy (24) 24
care and treatment (23) 23
mice (23) 23
patients (23) 23
antineoplastic agents - therapeutic use (22) 22
molecular sequence data (22) 22
survival rate (22) 22
time factors (21) 21
antibodies, monoclonal, murine-derived (20) 20
doxorubicin - therapeutic use (20) 20
antineoplastic combined chemotherapy protocols - adverse effects (19) 19
cyclophosphamide (19) 19
hematology, oncology and palliative medicine (19) 19
hodgkin disease - immunology (19) 19
stem cells (19) 19
transplantation (19) 19
vincristine - therapeutic use (19) 19
antibodies, monoclonal, murine-derived - administration & dosage (18) 18
combined modality therapy (18) 18
cyclophosphamide - therapeutic use (18) 18
lymphoma, large b-cell, diffuse - pathology (18) 18
polymerase chain reaction (18) 18
prednisone - therapeutic use (18) 18
research (18) 18
antigens (17) 17
cell line, tumor (17) 17
doxorubicin (17) 17
drug administration schedule (17) 17
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2092) 2092
French (75) 75
German (61) 61
Chinese (2) 2
Danish (2) 2
Korean (2) 2
Portuguese (2) 2
Spanish (2) 2
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet (British edition), ISSN 0140-6736, 05/2012, Volume 379, Issue 9828, pp. 1791 - 1799
Summary Background The intensity of chemotherapy and need for additional radiotherapy in patients with advanced stage Hodgkin's lymphoma has been unclear. We... 
Internal Medicine | Radiotherapy Dosage | Doxorubicin/adverse effects | Etoposide/adverse effects | Procarbazine/adverse effects | Prospective Studies | Hodgkin Disease/drug therapy | Humans | Middle Aged | Proportional Hazards Models | Male | Treatment Outcome | Positron-Emission Tomography | Antineoplastic Combined Chemotherapy Protocols/adverse effects | Prednisone/adverse effects | Treatment Failure | Adolescent | Survival Analysis | Adult | Female | Cyclophosphamide/adverse effects | Vincristine/adverse effects | Neoplasm Staging | Bleomycin/adverse effects | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Doxorubicin - therapeutic use | Hodgkin Disease - pathology | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Hodgkin Disease - radiotherapy | Bleomycin - therapeutic use | Hodgkin Disease - drug therapy | Etoposide - adverse effects | Prednisone - adverse effects | Etoposide - therapeutic use | Bleomycin - adverse effects | Procarbazine - adverse effects | Procarbazine - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Vincristine - therapeutic use | Vincristine - adverse effects | Doxorubicin - adverse effects | Prednisone - therapeutic use | Chemotherapy | Usage | Care and treatment | PET imaging | Diagnosis | Hodgkin's disease | Cancer | Medical imaging | Meetings | Patient safety | Oncology | Lymphomas | Histology | Radiation therapy | Ovarian cancer | Index Medicus | Abridged Index Medicus
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 02/2014, Volume 32, Issue 5, pp. 415 - 423
Purpose Deep molecular response (MR4.5) defines a subgroup of patients with chronic myeloid leukemia (CML) who may stay in unmaintained remission after... 
Life Sciences & Biomedicine | Oncology | Science & Technology | Piperazines - administration & dosage | Humans | Middle Aged | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics | Male | Protein Kinase Inhibitors - adverse effects | Molecular Targeted Therapy | Young Adult | Benzamides - administration & dosage | Time Factors | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology | Aged, 80 and over | Adult | Female | Benzamides - adverse effects | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - mortality | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - enzymology | Pyrimidines - administration & dosage | Risk Factors | Proportional Hazards Models | Treatment Outcome | Imatinib Mesylate | Piperazines - adverse effects | Remission Induction | Cytarabine - administration & dosage | Disease Progression | Interferon-alpha - administration & dosage | Disease-Free Survival | Protein Kinase Inhibitors - administration & dosage | Fusion Proteins, bcr-abl - genetics | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Fusion Proteins, bcr-abl - antagonists & inhibitors | Pyrimidines - adverse effects | Aged | Fusion Proteins, bcr-abl - metabolism | Index Medicus
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 02/2009, Volume 27, Issue 4, pp. 511 - 518
Purpose Mantle cell lymphomas (MCLs) represent a clinically aggressive lymphoma subtype with a poor prognosis. To explore a potential progress in outcome a... 
Life Sciences & Biomedicine | Oncology | Science & Technology | Lymphoma, Mantle-Cell - mortality | Lymphoma, Mantle-Cell - therapy | Humans | Middle Aged | Aged, 80 and over | Adult | Female | Male | Survival Rate | Aged | Index Medicus
Journal Article
Journal Article
The lancet oncology, ISSN 1470-2045, 12/2012, Volume 13, Issue 12, pp. 1250 - 1259
Journal Article
Journal Article